Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health ...

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...

Glenmark Pharma's stock rose after it said Glenmark Pharmaceuticals Inc., USA, has received final approval from the USFDA for ...

Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% ...

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...

Glenmark Pharmaceuticals rose 1.95% to Rs 1,506.95 after its US subsidiary, Glenmark Pharmaceuticals Inc., USA, received approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

Auditor/Auditors for Glenmark Pharmaceuticals Ltd is/are Suresh Surana & Associates LLP. In the main management, Glenn Saldanha is chairman and is the company secretary for Glenmark ...

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation ...